» Authors » Stefanie Finger

Stefanie Finger

Explore the profile of Stefanie Finger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 380
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Strohm L, Ubbens H, Mihalikova D, Czarnowski A, Stamm P, Molitor M, et al.
Redox Biol . 2025 Feb; 80:103520. PMID: 39899926
Cardiovascular disease is the leading cause of disease burden and death worldwide and is fueled by vascular inflammation. CD40L-CD40-TRAF signaling is involved in the progression of atherosclerosis and drives the...
2.
Garlapati V, Luo Q, Posma J, Aluia M, Nguyen T, Grunz K, et al.
Circ Res . 2024 Sep; 135(8):841-855. PMID: 39234697
Background: Excess fibrotic remodeling causes cardiac dysfunction in ischemic heart disease, driven by MAP (mitogen-activated protein) kinase-dependent TGF-ß1 (transforming growth factor-ß1) activation by coagulation signaling of myeloid cells. How coagulation-inflammatory...
3.
Knopp T, Jung R, Wild J, Bochenek M, Efentakis P, Lehmann A, et al.
Eur Heart J Open . 2024 Jul; 4(4):oeae046. PMID: 39015379
Aims: The cytokine interleukin-6 (IL-6) plays a central role in the inflammation cascade as well as cardiovascular disease progression. Since myeloid cells are a primary source of IL-6 formation, we...
4.
Keppeler K, Pesi A, Lange S, Helmstadter J, Strohm L, Ubbens H, et al.
Redox Biol . 2024 Feb; 70:103071. PMID: 38354629
Aims: We examined the cardiovascular effects of celiac disease (CeD) in a humanized mouse model, with a focus on vascular inflammation, endothelial dysfunction, and oxidative stress. Methods And Results: NOD.DQ8...
5.
Molitor M, Bayo-Jimenez M, Hahad O, Witzler C, Finger S, Garlapati V, et al.
Cardiovasc Res . 2023 Jan; 119(6):1416-1426. PMID: 36702626
Aims: Traffic noise may play an important role in the development and deterioration of ischaemic heart disease. Thus, we sought to determine the mechanisms of cardiovascular dysfunction and inflammation induced...
6.
Garlapati V, Molitor M, Michna T, Harms G, Finger S, Jung R, et al.
J Clin Invest . 2022 Dec; 133(4). PMID: 36548062
Despite major advances in acute interventions for myocardial infarction (MI), adverse cardiac remodeling and excess fibrosis after MI causing ischemic heart failure (IHF) remain a leading cause of death worldwide....
7.
Zhang L, Dietsche F, Seitaj B, Rojas-Charry L, Latchman N, Tomar D, et al.
Life Sci Alliance . 2022 Jun; 5(10). PMID: 35715207
Ion fluxes across the inner mitochondrial membrane control mitochondrial volume, energy production, and apoptosis. TMBIM5, a highly conserved protein with homology to putative pH-dependent ion channels, is involved in the...
8.
Efentakis P, Molitor M, Kossmann S, Bochenek M, Wild J, Lagrange J, et al.
Eur Heart J . 2021 Jun; 43(6):488-500. PMID: 34132336
Aims: Assessment of endothelial function in humans by measuring flow-mediated dilation (FMD) risk-stratifies individuals with established cardiovascular disease, whereas its predictive value is limited in primary prevention. We therefore aimed...
9.
Rudi W, Molitor M, Garlapati V, Finger S, Wild J, Munzel T, et al.
Antioxidants (Basel) . 2021 Apr; 10(3). PMID: 33807982
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a cornerstone of drug therapy after myocardial infarction (MI) and improve left ventricular function and survival. We aimed to elucidate the impact of early treatment...
10.
Lagrange J, Finger S, Kossmann S, Garlapati V, Ruf W, Wenzel P
Int J Mol Sci . 2020 Jul; 21(14). PMID: 32664652
Methods: LRP8 and LRP8 mice (on B6;129S background) were infused with angiotensin II (AngII, 1 mg/kg/day for 7 to 28 day) using osmotic minipumps. Blood pressure was recorded using tail...